Please login to the form below

Not currently logged in
Email:
Password:

Sanofi-aventis expands R&D in China

Sanofi-aventis has announced the establishment of a biometrics centre in Beijing as part of the expansion of its R&D facilities in China

Sanofi-aventis has announced the establishment of a biometrics centre in Beijing as part of the expansion of its R&D facilities in China.

The state-of-the-art centre will specialise in the design, data management and analysis of global and local trials, in both pharmaceuticals and vaccines development, through all four phases.

The French firm's partnership agreement with the Shanghai Institutes for Biological Sciences (SIBS) plays a key role in strengthening the company's R&D facilities. This partnership, which is part of the China Discovery platform set up by sanofi-aventis to build relationships with top Chinese academic institutions, aims to identify innovative, first-in-class drugs.

"This collaboration agreement brings pharmaceutical R&D in China to another level, by allowing talented Chinese scientists to become internationally recognised and ensuring that discoveries made in the area of basic research are rapidly converted into applications for treating diseases," said Dr Jia-Rui Wu, vice president of the SIBS.

Sanofi-aventis has also launched a scholarship programme in China to recognise promising scientists engaged in cutting-edge pharmaceutical R&D.

21st October 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...
Ali Frederic Ben-Amor
Tackling a formidable foe
Ali Frederic Ben-Amor tells how Merck is taking the fight to multiple sclerosis...

Infographics